MOSS BEACH, Calif.--(BUSINESS WIRE)--According to a landmark study published this month in the Journal of Managed Care Pharmacy and presented at the 4th Biennial Conference of the American Society of Health Economists held at the University of Minnesota, the most expensive skin substitutes (also known as “advanced wound care matrices”) for the treatment of venous leg ulcers (VLUs) may not provide the greatest clinical or cost efficacy. A copy of the published article, entitled “Clinical and Cost Efficacy of Advanced Wound Care Matrices for Venous Ulcers,” is available at: http://www.amcp.org/JMCP/2012/June/15295/1033.html.
